DOCN
DigitalOcean Holdings, Inc.
DOCN trails on the overall score without a compensating advantage in the available component scores.
PLTR
Palantir Technologies Inc.
PLTR has the edge over DOCN overall, supported by stronger valuation and stronger modeled upside.
DOCN Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Strong | |
| Strong |
DOCN's revenue, cash flow and balance sheet are currently strong, and its profitability is stable.
PLTR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
PLTR's revenue, profitability, cash flow and balance sheet are all currently strong.
DOCN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 25x | $7.61 | -92% |
| Fair | 46x | $13.68 | -85% |
| Forward | 55x | $90.07 | — |
| Expensive | 68x | $20.36 | -77% |
| Current | 300x | $90.07 | — |
Historical ranges are pointers, not guarantees.
DOCN's PE is in its expensive range at 300x. If earnings grow as analysts expect, today's price would be 55x next year's earnings, in its fair range.
PLTR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 75x | $172 | — |
| Current | 120x | $172 | — |
| Cheap | 165x | $236 | +37% |
| Fair | 251x | $359 | +109% |
| Expensive | 452x | $646 | +277% |
Historical ranges are pointers, not guarantees.
PLTR has the edge over DOCN in the historical PE scenario, which offers more potential upside but is not a forecast.
DOCN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for DOCN, but weaker profitability. However, they disagree widely on these estimates.
PLTR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
PLTR has the edge over DOCN on the outlook, with more favorable profitability expectations.
DOCN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.64 | +448% |
| Q3 2026 | $0.30 | -88% |
| Q2 2026 | $2.18 | +68% |
| Q1 2026 | $2.28 | +105% |
| Q4 2025 | $2.52 | +190% |
| Q3 2025 | $2.48 | +195% |
| Q2 2025 | $1.30 | +83% |
| Q1 2025 | $1.11 | +113% |
| Q4 2024 | $0.87 | +335% |
DOCN earned $0.30 per share over the past year, down 88% from the year before.
PLTR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.30 | +61% |
| Q3 2026 | $1.43 | +240% |
| Q2 2026 | $1.17 | +290% |
| Q1 2026 | $0.89 | +287% |
| Q4 2025 | $0.63 | +232% |
| Q3 2025 | $0.42 | +110% |
| Q2 2025 | $0.30 | +76% |
| Q1 2025 | $0.23 | +92% |
| Q4 2024 | $0.19 | +111% |
PLTR has the edge over DOCN on earnings, with more consistent year-over-year improvement.
DOCN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $321.2M | +40% |
| Q2 2026 | $281.2M | +29% |
| Q1 2026 | $257.9M | +22% |
| Q4 2025 | $242.4M | +18% |
| Q3 2025 | $229.6M | +16% |
| Q2 2025 | $218.7M | +14% |
| Q1 2025 | $210.7M | +14% |
| Q4 2024 | $204.9M | +13% |
DOCN's revenue has grown year over year every quarter since early 2021: $321M last quarter, up 40% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 10% | -9.3 points |
| Q2 2026 | 10% | -5.8 points |
| Q1 2026 | 14% | -3.7 points |
| Q4 2025 | 16% | +0.1 points |
| Q3 2025 | 20% | +7.2 points |
| Q2 2025 | 16% | +4.7 points |
| Q1 2025 | 18% | +12 points |
| Q4 2024 | 16% | +9.8 points |
DOCN's operating margin was 10% last quarter, down 9.3 points from the same quarter a year ago.
PLTR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.3B | +96% |
| Q2 2026 | $1.9B | +93% |
| Q1 2026 | $1.6B | +85% |
| Q4 2025 | $1.4B | +70% |
| Q3 2025 | $1.2B | +63% |
| Q2 2025 | $1B | +48% |
| Q1 2025 | $883.9M | +39% |
| Q4 2024 | $827.5M | +36% |
PLTR has the edge over DOCN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 47% | +14 points |
| Q2 2026 | 47% | +20 points |
| Q1 2026 | 46% | +26 points |
| Q4 2025 | 41% | +40 points |
| Q3 2025 | 33% | +18 points |
| Q2 2025 | 27% | +11 points |
| Q1 2025 | 20% | +7.2 points |
| Q4 2024 | 1.3% | -9.5 points |
PLTR has the edge over DOCN on profitability, with a higher operating margin.
DOCN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $137.7M | +56% |
| Q2 2026 | $68.4M | +15% |
| Q1 2026 | $6.9M | +226% |
| Q4 2025 | $31.1M | +19% |
| Q3 2025 | $88M | +450% |
| Q2 2025 | $59.3M | +50% |
| Q1 2025 | $2.1M | -91% |
| Q4 2024 | $26.1M | -7.9% |
DOCN generated $244M in free cash flow over the past year, up 39% from the year before.
PLTR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.2B | +139% |
| Q2 2026 | $1.2B | +126% |
| Q1 2026 | $891.8M | +193% |
| Q4 2025 | $764M | +67% |
| Q3 2025 | $500.9M | +20% |
| Q2 2025 | $531.6M | +276% |
| Q1 2025 | $304.1M | +140% |
| Q4 2024 | $457.2M | +54% |
PLTR has the edge over DOCN on cash flow, with more consistent year-over-year improvement.
DOCN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -9.4% | -11.9M shares |
| 1 year | +8.7% | +9.2M shares |
| 3 years | +12% | +12M shares |
| 5 years | +6.2% | +6.7M shares |
| Available history | +32% | +27.6M shares |
DOCN has 115M diluted shares, up 8.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $2.9M |
| Q2 2025 | $20.1M |
| Q1 2025 | $59.1M |
| Q4 2024 | $29.9M |
DOCN hasn't bought back shares in the past year.
PLTR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +5.2M shares |
| 1 year | +0.1% | +2.9M shares |
| 3 years | +11% | +248M shares |
| 5 years | +31% | +610M shares |
| Available history | +184% | +1.7B shares |
PLTR has the edge over DOCN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $19.2M |
| Q3 2025 | $19.2M |
| Q2 2025 | $18.6M |
| Q1 2025 | $18M |
| Q4 2024 | $18.6M |
| Q3 2024 | $18.9M |
| Q2 2024 | $17.7M |
| Q1 2024 | $9M |
DOCN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.6x | Net Cash |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 3.5x | Elevated |
| Q3 2025 | 3.8x | Elevated |
| Q2 2025 | 4.3x | High |
| Q1 2025 | 4.6x | High |
| Q4 2024 | 4.8x | High |
DOCN has more cash than debt.
PLTR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -1.1x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -1.9x | Net Cash |
| Q2 2025 | -1.6x | Net Cash |
| Q1 2025 | -2.3x | Net Cash |
| Q4 2024 | -6.1x | Net Cash |
PLTR has the edge over DOCN on leverage, with a lower net debt burden relative to earnings.
DOCN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.1 | Neutral |
| Stochastic | 11.0 | Oversold |
DOCN's weekly RSI is 42 (neutral) and its Stochastic is 11 (oversold).
PLTR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.4 | Neutral |
| Stochastic | 47.4 | Neutral |
PLTR's weekly RSI is 51 (neutral) and its Stochastic is 47 (neutral).
DOCN PE vs Technology Sector
| Metric | DOCN | Sector median | Relative |
|---|---|---|---|
| PE | 300x | 28x | 978% above |
| PE % | 100 | 41 | 59 pts above |
DOCN is trading at 300x earnings, a 978% premium to the Technology sector's median of 28x.
PLTR PE vs Technology Sector
| Metric | PLTR | Sector median | Relative |
|---|---|---|---|
| PE | 120x | 28x | 331% above |
| PE % | 1 | 38 | 37 pts below |
PLTR has the edge over DOCN on valuation relative to its sector.
DOCN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $107.3 | 16% below |
| 20 week MA | $116.3 | 23% below |
| 50 week MA | $101.1 | 11% below |
| 100 week MA | $68.0 | 33% above |
| 200 week MA | $51.5 | 75% above |
DOCN has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 75% above its 200-week average.
PLTR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $185.8 | 7.6% below |
| 20 week MA | $167.6 | 2.4% above |
| 50 week MA | $157.1 | 9.2% above |
| 100 week MA | $143.8 | 19% above |
| 200 week MA | $83.3 | 106% above |
PLTR has the edge over DOCN on trend strength, trading above more of its moving averages.
DOCN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $41.6 | $81.3 | +95% |
| 2022 | $81.3 | $24.8 | -70% |
| 2023 | $24.8 | $36.7 | +48% |
| 2024 | $36.7 | $34.9 | -4.8% |
| 2025 | $34.9 | $49.5 | +42% |
| 2026 YTD | $49.5 | $90.1 | +82% |
DOCN has the edge over PLTR on returns for 2026, with the stronger performance.
PLTR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.20 | $27.8 | +202% |
| 2021 | $27.8 | $18.9 | -32% |
| 2022 | $18.9 | $6.29 | -67% |
| 2023 | $6.29 | $17.2 | +173% |
| 2024 | $17.2 | $79.1 | +361% |
| 2025 | $79.1 | $188.7 | +139% |
| 2026 YTD | $188.7 | $171.6 | -9.1% |
PLTR's yearly returns have swung widely, from +361% in 2024 to −67% in 2022. It's down 9.1% so far in 2026.